CN1509774A - 一种药物涂层心血管支架的涂层制备方法 - Google Patents
一种药物涂层心血管支架的涂层制备方法 Download PDFInfo
- Publication number
- CN1509774A CN1509774A CNA021569401A CN02156940A CN1509774A CN 1509774 A CN1509774 A CN 1509774A CN A021569401 A CNA021569401 A CN A021569401A CN 02156940 A CN02156940 A CN 02156940A CN 1509774 A CN1509774 A CN 1509774A
- Authority
- CN
- China
- Prior art keywords
- coating
- support
- medication coat
- coating production
- angiocarpy bracket
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- 239000003814 drug Substances 0.000 title claims abstract description 37
- 238000000034 method Methods 0.000 title claims abstract description 16
- 238000000576 coating method Methods 0.000 title claims description 50
- 239000011248 coating agent Substances 0.000 title claims description 48
- 230000002526 effect on cardiovascular system Effects 0.000 title 1
- 238000004519 manufacturing process Methods 0.000 claims abstract description 20
- 229920000642 polymer Polymers 0.000 claims abstract description 14
- 229940079593 drug Drugs 0.000 claims description 24
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Chemical compound O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims description 19
- OKKJLVBELUTLKV-UHFFFAOYSA-N Methanol Chemical compound OC OKKJLVBELUTLKV-UHFFFAOYSA-N 0.000 claims description 18
- 235000021110 pickles Nutrition 0.000 claims description 14
- CSCPPACGZOOCGX-UHFFFAOYSA-N Acetone Chemical compound CC(C)=O CSCPPACGZOOCGX-UHFFFAOYSA-N 0.000 claims description 12
- 239000012153 distilled water Substances 0.000 claims description 12
- 238000009413 insulation Methods 0.000 claims description 11
- 238000003618 dip coating Methods 0.000 claims description 10
- VEXZGXHMUGYJMC-UHFFFAOYSA-N Hydrochloric acid Chemical compound Cl VEXZGXHMUGYJMC-UHFFFAOYSA-N 0.000 claims description 6
- 239000003292 glue Substances 0.000 claims description 6
- VKYKSIONXSXAKP-UHFFFAOYSA-N hexamethylenetetramine Chemical compound C1N(C2)CN3CN1CN2C3 VKYKSIONXSXAKP-UHFFFAOYSA-N 0.000 claims description 6
- 238000007711 solidification Methods 0.000 claims description 6
- 230000008023 solidification Effects 0.000 claims description 6
- JHWIEAWILPSRMU-UHFFFAOYSA-N 2-methyl-3-pyrimidin-4-ylpropanoic acid Chemical compound OC(=O)C(C)CC1=CC=NC=N1 JHWIEAWILPSRMU-UHFFFAOYSA-N 0.000 claims description 5
- 229930012538 Paclitaxel Natural products 0.000 claims description 5
- 229960001592 paclitaxel Drugs 0.000 claims description 5
- 229920003229 poly(methyl methacrylate) Polymers 0.000 claims description 5
- 239000004926 polymethyl methacrylate Substances 0.000 claims description 5
- 239000000126 substance Substances 0.000 claims description 5
- RCINICONZNJXQF-MZXODVADSA-N taxol Chemical compound O([C@@H]1[C@@]2(C[C@@H](C(C)=C(C2(C)C)[C@H](C([C@]2(C)[C@@H](O)C[C@H]3OC[C@]3([C@H]21)OC(C)=O)=O)OC(=O)C)OC(=O)[C@H](O)[C@@H](NC(=O)C=1C=CC=CC=1)C=1C=CC=CC=1)O)C(=O)C1=CC=CC=C1 RCINICONZNJXQF-MZXODVADSA-N 0.000 claims description 5
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 claims description 4
- GRYLNZFGIOXLOG-UHFFFAOYSA-N Nitric acid Chemical compound O[N+]([O-])=O GRYLNZFGIOXLOG-UHFFFAOYSA-N 0.000 claims description 4
- 239000002253 acid Substances 0.000 claims description 4
- RJURFGZVJUQBHK-UHFFFAOYSA-N actinomycin D Natural products CC1OC(=O)C(C(C)C)N(C)C(=O)CN(C)C(=O)C2CCCN2C(=O)C(C(C)C)NC(=O)C1NC(=O)C1=C(N)C(=O)C(C)=C2OC(C(C)=CC=C3C(=O)NC4C(=O)NC(C(N5CCCC5C(=O)N(C)CC(=O)N(C)C(C(C)C)C(=O)OC4C)=O)C(C)C)=C3N=C21 RJURFGZVJUQBHK-UHFFFAOYSA-N 0.000 claims description 4
- 229910017604 nitric acid Inorganic materials 0.000 claims description 4
- -1 polyethylene Polymers 0.000 claims description 4
- 238000004381 surface treatment Methods 0.000 claims description 4
- 238000001291 vacuum drying Methods 0.000 claims description 4
- 238000010792 warming Methods 0.000 claims description 4
- MHAJPDPJQMAIIY-UHFFFAOYSA-N Hydrogen peroxide Chemical compound OO MHAJPDPJQMAIIY-UHFFFAOYSA-N 0.000 claims description 3
- QAOWNCQODCNURD-UHFFFAOYSA-N Sulfuric acid Chemical compound OS(O)(=O)=O QAOWNCQODCNURD-UHFFFAOYSA-N 0.000 claims description 3
- UREBDLICKHMUKA-CXSFZGCWSA-N dexamethasone Chemical compound C1CC2=CC(=O)C=C[C@]2(C)[C@]2(F)[C@@H]1[C@@H]1C[C@@H](C)[C@@](C(=O)CO)(O)[C@@]1(C)C[C@@H]2O UREBDLICKHMUKA-CXSFZGCWSA-N 0.000 claims description 3
- 229960003957 dexamethasone Drugs 0.000 claims description 3
- 235000010299 hexamethylene tetramine Nutrition 0.000 claims description 3
- 239000004312 hexamethylene tetramine Substances 0.000 claims description 3
- 229920002635 polyurethane Polymers 0.000 claims description 3
- 239000004814 polyurethane Substances 0.000 claims description 3
- 239000012047 saturated solution Substances 0.000 claims description 3
- 239000001117 sulphuric acid Substances 0.000 claims description 3
- 235000011149 sulphuric acid Nutrition 0.000 claims description 3
- PMATZTZNYRCHOR-CGLBZJNRSA-N Cyclosporin A Chemical compound CC[C@@H]1NC(=O)[C@H]([C@H](O)[C@H](C)C\C=C\C)N(C)C(=O)[C@H](C(C)C)N(C)C(=O)[C@H](CC(C)C)N(C)C(=O)[C@H](CC(C)C)N(C)C(=O)[C@@H](C)NC(=O)[C@H](C)NC(=O)[C@H](CC(C)C)N(C)C(=O)[C@H](C(C)C)NC(=O)[C@H](CC(C)C)N(C)C(=O)CN(C)C1=O PMATZTZNYRCHOR-CGLBZJNRSA-N 0.000 claims description 2
- 229930105110 Cyclosporin A Natural products 0.000 claims description 2
- 108010092160 Dactinomycin Proteins 0.000 claims description 2
- HTTJABKRGRZYRN-UHFFFAOYSA-N Heparin Chemical compound OC1C(NC(=O)C)C(O)OC(COS(O)(=O)=O)C1OC1C(OS(O)(=O)=O)C(O)C(OC2C(C(OS(O)(=O)=O)C(OC3C(C(O)C(O)C(O3)C(O)=O)OS(O)(=O)=O)C(CO)O2)NS(O)(=O)=O)C(C(O)=O)O1 HTTJABKRGRZYRN-UHFFFAOYSA-N 0.000 claims description 2
- 206010020880 Hypertrophy Diseases 0.000 claims description 2
- 239000004952 Polyamide Substances 0.000 claims description 2
- 239000004698 Polyethylene Substances 0.000 claims description 2
- 239000002202 Polyethylene glycol Substances 0.000 claims description 2
- 239000004642 Polyimide Substances 0.000 claims description 2
- 229920000388 Polyphosphate Polymers 0.000 claims description 2
- 229920002125 Sokalan® Polymers 0.000 claims description 2
- RJURFGZVJUQBHK-IIXSONLDSA-N actinomycin D Chemical compound C[C@H]1OC(=O)[C@H](C(C)C)N(C)C(=O)CN(C)C(=O)[C@@H]2CCCN2C(=O)[C@@H](C(C)C)NC(=O)[C@H]1NC(=O)C1=C(N)C(=O)C(C)=C2OC(C(C)=CC=C3C(=O)N[C@@H]4C(=O)N[C@@H](C(N5CCC[C@H]5C(=O)N(C)CC(=O)N(C)[C@@H](C(C)C)C(=O)O[C@@H]4C)=O)C(C)C)=C3N=C21 RJURFGZVJUQBHK-IIXSONLDSA-N 0.000 claims description 2
- 230000010100 anticoagulation Effects 0.000 claims description 2
- 238000005119 centrifugation Methods 0.000 claims description 2
- 230000009514 concussion Effects 0.000 claims description 2
- 229920001577 copolymer Polymers 0.000 claims description 2
- 229960000640 dactinomycin Drugs 0.000 claims description 2
- 239000000835 fiber Substances 0.000 claims description 2
- 239000012530 fluid Substances 0.000 claims description 2
- 238000011010 flushing procedure Methods 0.000 claims description 2
- SYUXAJSOZXEFPP-UHFFFAOYSA-N glutin Natural products COc1c(O)cc2OC(=CC(=O)c2c1O)c3ccccc3OC4OC(CO)C(O)C(O)C4O SYUXAJSOZXEFPP-UHFFFAOYSA-N 0.000 claims description 2
- 229960002897 heparin Drugs 0.000 claims description 2
- 229920000669 heparin Polymers 0.000 claims description 2
- 238000005554 pickling Methods 0.000 claims description 2
- 229950000845 politef Drugs 0.000 claims description 2
- 229920000747 poly(lactic acid) Polymers 0.000 claims description 2
- 229920000052 poly(p-xylylene) Polymers 0.000 claims description 2
- 229920002401 polyacrylamide Polymers 0.000 claims description 2
- 229920000058 polyacrylate Polymers 0.000 claims description 2
- 239000004584 polyacrylic acid Substances 0.000 claims description 2
- 229920002647 polyamide Polymers 0.000 claims description 2
- 229920001610 polycaprolactone Polymers 0.000 claims description 2
- 239000004632 polycaprolactone Substances 0.000 claims description 2
- 229920000728 polyester Polymers 0.000 claims description 2
- 229920000573 polyethylene Polymers 0.000 claims description 2
- 229920001223 polyethylene glycol Polymers 0.000 claims description 2
- 229920001721 polyimide Polymers 0.000 claims description 2
- 239000001205 polyphosphate Substances 0.000 claims description 2
- 235000011176 polyphosphates Nutrition 0.000 claims description 2
- 229920001296 polysiloxane Polymers 0.000 claims description 2
- 239000002464 receptor antagonist Substances 0.000 claims description 2
- 229940044551 receptor antagonist Drugs 0.000 claims description 2
- 229920002379 silicone rubber Polymers 0.000 claims description 2
- 239000004945 silicone rubber Substances 0.000 claims description 2
- 238000002604 ultrasonography Methods 0.000 claims description 2
- 229920001688 coating polymer Polymers 0.000 claims 1
- 238000005516 engineering process Methods 0.000 abstract description 6
- 239000000463 material Substances 0.000 abstract description 3
- 239000000758 substrate Substances 0.000 abstract 1
- 239000000084 colloidal system Substances 0.000 description 17
- XEKOWRVHYACXOJ-UHFFFAOYSA-N Ethyl acetate Chemical compound CCOC(C)=O XEKOWRVHYACXOJ-UHFFFAOYSA-N 0.000 description 9
- 238000002360 preparation method Methods 0.000 description 9
- 238000004506 ultrasonic cleaning Methods 0.000 description 7
- 239000000203 mixture Substances 0.000 description 6
- 239000011159 matrix material Substances 0.000 description 5
- BLRPTPMANUNPDV-UHFFFAOYSA-N Silane Chemical compound [SiH4] BLRPTPMANUNPDV-UHFFFAOYSA-N 0.000 description 4
- 230000002950 deficient Effects 0.000 description 4
- 229910052751 metal Inorganic materials 0.000 description 4
- 239000002184 metal Substances 0.000 description 4
- 229910000077 silane Inorganic materials 0.000 description 4
- 229910001220 stainless steel Inorganic materials 0.000 description 4
- 239000010935 stainless steel Substances 0.000 description 4
- 206010013786 Dry skin Diseases 0.000 description 3
- 238000001035 drying Methods 0.000 description 3
- 238000000608 laser ablation Methods 0.000 description 3
- 238000011417 postcuring Methods 0.000 description 3
- QGZKDVFQNNGYKY-UHFFFAOYSA-N Ammonia Chemical compound N QGZKDVFQNNGYKY-UHFFFAOYSA-N 0.000 description 2
- 239000008280 blood Substances 0.000 description 2
- 210000004369 blood Anatomy 0.000 description 2
- 238000010438 heat treatment Methods 0.000 description 2
- 239000003960 organic solvent Substances 0.000 description 2
- 208000037803 restenosis Diseases 0.000 description 2
- 206010057469 Vascular stenosis Diseases 0.000 description 1
- 230000002411 adverse Effects 0.000 description 1
- 239000003513 alkali Substances 0.000 description 1
- 229910021529 ammonia Inorganic materials 0.000 description 1
- 230000000903 blocking effect Effects 0.000 description 1
- 210000004204 blood vessel Anatomy 0.000 description 1
- 238000006243 chemical reaction Methods 0.000 description 1
- 239000008199 coating composition Substances 0.000 description 1
- 238000000366 colloid method Methods 0.000 description 1
- 210000004351 coronary vessel Anatomy 0.000 description 1
- 239000003431 cross linking reagent Substances 0.000 description 1
- 230000008021 deposition Effects 0.000 description 1
- 125000005442 diisocyanate group Chemical group 0.000 description 1
- 238000007599 discharging Methods 0.000 description 1
- 239000003937 drug carrier Substances 0.000 description 1
- 230000000694 effects Effects 0.000 description 1
- 238000007654 immersion Methods 0.000 description 1
- 239000012535 impurity Substances 0.000 description 1
- 238000000465 moulding Methods 0.000 description 1
- 230000008520 organization Effects 0.000 description 1
- 230000002980 postoperative effect Effects 0.000 description 1
- ZAHRKKWIAAJSAO-UHFFFAOYSA-N rapamycin Natural products COCC(O)C(=C/C(C)C(=O)CC(OC(=O)C1CCCCN1C(=O)C(=O)C2(O)OC(CC(OC)C(=CC=CC=CC(C)CC(C)C(=O)C)C)CCC2C)C(C)CC3CCC(O)C(C3)OC)C ZAHRKKWIAAJSAO-UHFFFAOYSA-N 0.000 description 1
- 239000002994 raw material Substances 0.000 description 1
- 229920006395 saturated elastomer Polymers 0.000 description 1
- 238000007086 side reaction Methods 0.000 description 1
- 229960002930 sirolimus Drugs 0.000 description 1
- QFJCIRLUMZQUOT-HPLJOQBZSA-N sirolimus Chemical compound C1C[C@@H](O)[C@H](OC)C[C@@H]1C[C@@H](C)[C@H]1OC(=O)[C@@H]2CCCCN2C(=O)C(=O)[C@](O)(O2)[C@H](C)CC[C@H]2C[C@H](OC)/C(C)=C/C=C/C=C/[C@@H](C)C[C@@H](C)C(=O)[C@H](OC)[C@H](O)/C(C)=C/[C@@H](C)C(=O)C1 QFJCIRLUMZQUOT-HPLJOQBZSA-N 0.000 description 1
- 239000002904 solvent Substances 0.000 description 1
- 230000001225 therapeutic effect Effects 0.000 description 1
Images
Landscapes
- Materials For Medical Uses (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Abstract
Description
Claims (9)
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CNB021569401A CN1244314C (zh) | 2002-12-25 | 2002-12-25 | 一种药物涂层心血管支架的涂层制备方法 |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CNB021569401A CN1244314C (zh) | 2002-12-25 | 2002-12-25 | 一种药物涂层心血管支架的涂层制备方法 |
Publications (2)
Publication Number | Publication Date |
---|---|
CN1509774A true CN1509774A (zh) | 2004-07-07 |
CN1244314C CN1244314C (zh) | 2006-03-08 |
Family
ID=34236459
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CNB021569401A Expired - Lifetime CN1244314C (zh) | 2002-12-25 | 2002-12-25 | 一种药物涂层心血管支架的涂层制备方法 |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN1244314C (zh) |
Cited By (10)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN100336566C (zh) * | 2005-11-18 | 2007-09-12 | 原子高科股份有限公司 | 药物涂层支架涂层的方法及其专用装置 |
CN100374092C (zh) * | 2005-01-14 | 2008-03-12 | 大连理工大学 | 一种血管支架的药物涂层制备方法及其静电喷涂装置 |
CN100435861C (zh) * | 2006-11-27 | 2008-11-26 | 中国医学科学院生物医学工程研究所 | 载药或载基因支架的制备方法 |
CN102114273A (zh) * | 2009-12-30 | 2011-07-06 | 微创医疗器械(上海)有限公司 | 一种自扩张药物支架及其制备方法 |
CN102274553A (zh) * | 2011-05-16 | 2011-12-14 | 天津大学 | 具有抗凝血作用的冠状动脉支架及制备方法 |
CN102416203A (zh) * | 2011-11-29 | 2012-04-18 | 北京中孵友信医药科技股份有限公司 | 具有局部抗血小板效应的rna干扰血管支架涂层材料及其制成的局部抗凝血管支架 |
CN101642586B (zh) * | 2008-08-06 | 2013-01-30 | 中国科学院金属研究所 | 一种制备含硅羟基磷酸钙涂层的仿生方法 |
CN103549976A (zh) * | 2013-11-11 | 2014-02-05 | 深圳市开立科技有限公司 | 一种超声探头、医用内镜及其加工方法 |
CN106319531A (zh) * | 2016-10-31 | 2017-01-11 | 东兰音乐铜鼓文化传播有限责任公司 | 一种青铜铜鼓的防腐方法 |
CN114432499A (zh) * | 2021-12-20 | 2022-05-06 | 脉通医疗科技(嘉兴)有限公司 | 人工血管及其制备方法 |
Families Citing this family (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN100441239C (zh) * | 2006-08-10 | 2008-12-10 | 原子高科股份有限公司 | 以海藻酸盐为载体的药物涂层支架的涂层制备方法 |
CN101313873B (zh) * | 2007-05-31 | 2011-03-23 | 乐普(北京)医疗器械股份有限公司 | 一种生物多肽药物血管支架及其制备方法 |
CN101385669B (zh) * | 2007-09-12 | 2010-12-08 | 中国科学院金属研究所 | 一种抗凝血不锈钢冠动脉支架及其应用 |
-
2002
- 2002-12-25 CN CNB021569401A patent/CN1244314C/zh not_active Expired - Lifetime
Cited By (12)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN100374092C (zh) * | 2005-01-14 | 2008-03-12 | 大连理工大学 | 一种血管支架的药物涂层制备方法及其静电喷涂装置 |
CN100336566C (zh) * | 2005-11-18 | 2007-09-12 | 原子高科股份有限公司 | 药物涂层支架涂层的方法及其专用装置 |
CN100435861C (zh) * | 2006-11-27 | 2008-11-26 | 中国医学科学院生物医学工程研究所 | 载药或载基因支架的制备方法 |
CN101642586B (zh) * | 2008-08-06 | 2013-01-30 | 中国科学院金属研究所 | 一种制备含硅羟基磷酸钙涂层的仿生方法 |
CN102114273A (zh) * | 2009-12-30 | 2011-07-06 | 微创医疗器械(上海)有限公司 | 一种自扩张药物支架及其制备方法 |
CN102274553A (zh) * | 2011-05-16 | 2011-12-14 | 天津大学 | 具有抗凝血作用的冠状动脉支架及制备方法 |
CN102416203A (zh) * | 2011-11-29 | 2012-04-18 | 北京中孵友信医药科技股份有限公司 | 具有局部抗血小板效应的rna干扰血管支架涂层材料及其制成的局部抗凝血管支架 |
CN102416203B (zh) * | 2011-11-29 | 2013-10-23 | 北京中孵友信医药科技股份有限公司 | 具有局部抗血小板效应的rna干扰血管支架涂层材料及其制成的局部抗凝血管支架 |
CN103549976A (zh) * | 2013-11-11 | 2014-02-05 | 深圳市开立科技有限公司 | 一种超声探头、医用内镜及其加工方法 |
CN106319531A (zh) * | 2016-10-31 | 2017-01-11 | 东兰音乐铜鼓文化传播有限责任公司 | 一种青铜铜鼓的防腐方法 |
CN114432499A (zh) * | 2021-12-20 | 2022-05-06 | 脉通医疗科技(嘉兴)有限公司 | 人工血管及其制备方法 |
CN114432499B (zh) * | 2021-12-20 | 2023-02-17 | 浙江脉通智造科技(集团)有限公司 | 人工血管及其制备方法 |
Also Published As
Publication number | Publication date |
---|---|
CN1244314C (zh) | 2006-03-08 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN1244314C (zh) | 一种药物涂层心血管支架的涂层制备方法 | |
CN104189963B (zh) | 降低可全降解镁合金血管支架降解速率的表面涂层制备方法 | |
US6656506B1 (en) | Microparticle coated medical device | |
US8173196B2 (en) | Method of coating a stent with a polysaccharide layer and associated stents | |
CN102210616B (zh) | 完全可降解聚合物药物洗脱支架及其制备方法 | |
JP2008527117A (ja) | ポリマー含有被覆物によってポリマー表面を被覆する方法、およびポリマー被覆ポリマーを含む物品 | |
CN1465410A (zh) | 一种具有多层涂层的药物洗脱支架 | |
JP2007532187A (ja) | 生物活性物質のためのコーティング組成物 | |
CN110075369B (zh) | 运用多层设计调节降解速率的金属-高分子复合支架及其制备方法和应用 | |
CN1225292C (zh) | 适用于医疗器件的涂料 | |
CN1223385C (zh) | 一种具有控制释放治疗性药物的心血管支架 | |
Wang et al. | Thermo-triggered ultrafast self-healing of microporous coating for on-demand encapsulation of biomacromolecules | |
CN1792387A (zh) | 载药缓释微/纳米球消化道支架的制备方法 | |
Fakhraei et al. | Nanofibrous polycaprolactone/chitosan membranes for preventing postsurgical tendon adhesion | |
CN1575189A (zh) | 支架 | |
CN110180038A (zh) | 具药物缓释功能超高柔性涂层的锌合金血管支架材料 | |
CN109091702A (zh) | 用于人体植入材料表面明胶微球载药生物活性涂层的制备方法及产品和应用 | |
CN1191099C (zh) | 一种药物包被血管支架 | |
CN1557507A (zh) | 防再狭窄药物缓释型血管支架及其制备方法 | |
JP2003033439A (ja) | コーティングステントおよびその製造方法 | |
CN1878579A (zh) | 制备药物洗脱医疗器械的方法和由该方法得到的医疗器械 | |
CN102327862A (zh) | 一种可降低镁基材料及其器件腐蚀速率的聚合物复合涂层技术 | |
CN110124115A (zh) | 疏水涂层、其制备方法、应用及可吸收植入式器械 | |
JP6647890B2 (ja) | シート状積層体およびシート状積層体の製造方法 | |
KR102627980B1 (ko) | 전기방사장치를 이용한 스텐트 코팅 방법 |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
C06 | Publication | ||
PB01 | Publication | ||
C10 | Entry into substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
C14 | Grant of patent or utility model | ||
GR01 | Patent grant | ||
ASS | Succession or assignment of patent right |
Owner name: STATE ADVISORY ASSET INVESTMENT MANAGEMENT CO., LT Free format text: FORMER OWNER: METAL INST., CHINESE ACADEMY OF SCIENCES Effective date: 20090918 |
|
C41 | Transfer of patent application or patent right or utility model | ||
TR01 | Transfer of patent right |
Effective date of registration: 20090918 Address after: Tower 18, Henderson Center, No. 1703 inner main street, Beijing, Jianguomen Patentee after: National Asset Management Consulting Co.,Ltd. Address before: No. 72, Wenhua Road, Shenhe District, Liaoning, Shenyang Patentee before: INSTITUTE OF METAL RESEARCH CHINESE ACADEMY OF SCIENCES |
|
ASS | Succession or assignment of patent right |
Owner name: ZHONGKE YI'AN MEDICAL TECHNOLOGY (BEIJING) CO., LT Free format text: FORMER OWNER: NATIONAL ADVISORY ASSET INVESTMENT MANAGEMENT CO., LTD. Effective date: 20101214 |
|
C41 | Transfer of patent application or patent right or utility model | ||
COR | Change of bibliographic data |
Free format text: CORRECT: ADDRESS; FROM: 100005 1703, TOWER 1, OFFICE BUILDING, HENDERSON CENTER, NO.18, JIANGUOMEN INNER STREET, BEIJING TO: 101318 6/F, NO.2, ANXIANG AVENUE, AREA B, DEVELOPMENT ZONE, KONGGANG, SHUNYI DISTRICT, BEIJING |
|
TR01 | Transfer of patent right |
Effective date of registration: 20101214 Address after: 101318 Beijing city B District of Shunyi District Airport Development Zone Anxiang Street No. 2 six floor Patentee after: In the Department of science and Technology (Beijing) Yian Medical Co.,Ltd. Address before: 100005, 18, Henderson central office building, No. 1703 inner main street, Beijing, Jianguomen Patentee before: National Asset Management Consulting Co.,Ltd. |
|
C56 | Change in the name or address of the patentee | ||
CP01 | Change in the name or title of a patent holder |
Address after: 101318 Beijing city B District of Shunyi District Airport Development Zone Anxiang Street No. 2 six floor Patentee after: ZHONGKE YI'AN MEDICAL TECHNOLOGY (BEIJING) CO.,LTD. Address before: 101318 Beijing city B District of Shunyi District Airport Development Zone Anxiang Street No. 2 six floor Patentee before: In the Department of science and Technology (Beijing) Yian Medical Co.,Ltd. |
|
CX01 | Expiry of patent term | ||
CX01 | Expiry of patent term |
Granted publication date: 20060308 |